The Global Radiation Therapy Market is likely to gain momentum from the ever increasing demand for non-invasive treatment options for cancer. According to a report by Fortune Business Insights, titled, “Radiation Therapy Market Size, Share and Global Trend By Type (External Beam Radiation Therapy, Internal radiation therapy (brachytherapy), Others), By End Users (Hospitals & Diagnostic Laboratories, Cancer Treatment & Research Centers, Academic Research Organizations, Others) and Geography Forecast till 2026,” there is a rise in the prevalence of different types of cancers across the world. This is anticipated to fuel the global radiation therapy market sales during the forecast period.
Renowned Key Players Focus on Product Launches to Gain Fast Track FDA Approvals
DOSIsoft SA, a leading provider of innovative solutions, based in France, announced in March 2019 that it has received FDA approval to market PLANET Onco Dose software. The software offers personalized 3D dosimetry solution for 90Yttrium-based SIRT. In other words, it aids in diagnosing medical complications and internal dosimetry computation. It is also dedicated to therapy response assessment aid with the help of molecular imaging modalities. It is likely to augment the global radiation therapy market during the forecast period.
ViewRay Technologies, Inc., a provider of innovative radiation therapy techniques, headquartered in Ohio, announced that it has received FDA approval for the commercialization of new soft tissue visualization capabilities in February 2019. The main aim of this was to enhance the features of its MRIdian MRI-Guided Radiation Therapy System. It would help in reducing the treatment delivery time through MLC speed.
Key players leading the Global Radiation Therapy Market include
- Panacea Medical Technologies Pvt. Ltd.,
- Elekta AB,
- Provision Healthcare,
- Varian Medical Systems, Inc.,
- INC Isoray Inc.,
- DOSIsoft SA,
- Accuray Incorporated,
- Mevion Medical Systems,
- Viewray Technologies,
More Trending Topics From Fortune Business [email protected]
Inflammatory Bowel Diseases Therapeutics Market is Expected to Growth By Top Key Vendors | GlaxoSmithKline Plc and Merck & Co., Inc., AbbVie Inc., Janssen Pharmaceuticals Inc., Novartis AG, Pfizer Inc.
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.